8-KThe WireRoutine
Bylaw Amendment
Filed Feb 6, 2026 · 4mo ago · Accession 0001193125-26-041201
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Eikon Therapeutics, Inc.
- Ticker
- EIKN
- CIK
- 1861123
- Form type
- 8-K
- Filing date
- Feb 6, 2026
- Report date
- Feb 6, 2026
- Document
- d49647d8k.htm
- Size
- 193 KB